|
Glucose intolerance
Citations 1-10 of 141 total displayed.
|
Most recent content
(1 Dec 2009):
|
- Original Articles
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome
- Chiara Marchesi, Talin Ebrahimian, Orlando Angulo, Pierre Paradis, and Ernesto L. Schiffrin
Hypertension 2009;54:1384-1392; published online before print as doi:10.1161/HYPERTENSIONAHA.109.138305
[Abstract]
[Full text]
|
Past content
(since Feb 2001):
|
- Editorial Commentaries
Aortic Stiffness, Impaired Fasting Glucose, and Aging
- Thore Dietrich, Ute Schaefer-Graf, Eckart Fleck, and Kristof Graf
Hypertension published November 23, 2009, doi:10.1161/HYPERTENSIONAHA.109.135897
[Abstract]
- Scientific Contributions
Modification of the Effect of Glycemic Status on Aortic Distensibility by Age in the Multi-Ethnic Study of Atherosclerosis
- R. Brandon Stacey, Alain G. Bertoni, John Eng, David A. Bluemke, W. Gregory Hundley, and David Herrington
Hypertension published November 23, 2009, doi:10.1161/HYPERTENSIONAHA.109.134031
[Abstract]
- Scientific Contributions
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications
- Rhonda M. Cooper-DeHoff, Sheron Wen, Amber L. Beitelshees, Issam Zineh, John G. Gums, Stephen T. Turner, Yan Gong, Karen Hall, Vishal Parekh, Arlene B. Chapman, Eric Boerwinkle, and Julie A. Johnson
Hypertension published November 16, 2009, doi:10.1161/HYPERTENSIONAHA.109.139592
[Abstract]
- Scientific Contributions
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome
- Chiara Marchesi, Talin Ebrahimian, Orlando Angulo, Pierre Paradis, and Ernesto L. Schiffrin
Hypertension published October 12, 2009, doi:10.1161/HYPERTENSIONAHA.109.138305
[Abstract]
- Editorial Commentaries
Losartan Metabolite EXP3179: An AT1-Receptor–Independent Treatment Strategy for Patients With the Metabolic Syndrome?
- Gian Paolo Rossi
Hypertension 2009;54:710-712; published online before print as doi:10.1161/HYPERTENSIONAHA.109.138883
[Full text]
- Editorial Commentaries
Hypertension and Insulin Resistance
- Adam Whaley-Connell and James R. Sowers
Hypertension 2009;54:462-464; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134460
[Full text]
- Original Articles
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk: Effects of Acetyl-L-Carnitine Therapy
- Piero Ruggenenti, Dario Cattaneo, Giacomina Loriga, Franca Ledda, Nicola Motterlini, Giulia Gherardi, Silvia Orisio, and Giuseppe Remuzzi
Hypertension 2009;54:567-574; published online before print as doi:10.1161/HYPERTENSIONAHA.109.132522
[Abstract]
[Full text]
- Editorial Commentaries
Losartan Metabolite EXP3179. An AT1-Receptor–Independent Treatment Strategy for Patients With the Metabolic Syndrome?
- Gian Paolo Rossi
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.138883
[Abstract]
- Editorial Commentary
Hypertension and Insulin Resistance
- Adam Whaley-Connell and James R. Sowers
Hypertension published July 27, 2009, doi:10.1161/HYPERTENSIONAHA.109.134460
[Abstract]
|
|
